TNFSF10 and type 1 diabetes mellitus: These limitations were addressed in a subsequent pilot study of the same group, which reported a significant increase of serum TRAIL levels shortly after the initiation of insulin treatment in newly diagnosed pediatric patients with T1DM and ketoacidosis, and also a strong inverse correlation between circulating TRAIL levels and the degree of metabolic decompensation assessed by blood gas analysis [54].